For Your Information
FTC Approves Final Order Settling Charges that Johnson & Johnson's Proposed Acquisition of Synthes, Inc. was Anticompetitive in Market for Treating Traumatic Wrist Injuries
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Johnson & Johnson's proposed acquisition of Synthes, Inc. would have been anticompetitive in the market for surgical systems used to treat traumatic distal radius wrist fractures. The final FTC order resolving the charges requires Johnson & Johnson to sell its system for surgically treating serious wrist fractures.
The Commission vote approving the final order was 5-0. (FTC File No. 111-0160; Docket No. C-4363; the staff contact is Mark D. Seidman, Bureau of Competition, 202-326-3296; see press release dated June 11, 2012.)
(FYI 24.2012.wpd)
The Federal Trade Commission works to promote competition, and to protect and educate consumers. The FTC will never demand money, make threats, tell you to transfer money, or promise you a prize. You can learn more about how competition benefits consumers, file an antitrust complaint, or comment on a proposed merger. For the latest news and resources, follow the FTC on social media, subscribe to press releases, and read our blog.
Contact Information
MEDIA CONTACT:
Office of Public Affairs
202-326-2180